Jay Wang

Dr. Wang has worked over 20 years in Pharmaceutical, Biotech industry, and medical science fields. Prior to starting Zenomics Inc., Dr. Wang was the co-founder and CEO of CytoFlow, LLC, co-founder and CSO of BioMedomics Inc. and founder of two consulting firms.

Before the startup of his own companies, Dr. Wang worked at GSK, RTP focusing on cutting edge technologies for drug discovery, and worked at Toagosei LLC, Tsukuba, Japan, where he was leading the pre-clinical study of an anti-cancer drug.

Dr. Wang received awards from GlaxoSmithKline, The Osaka Foundation for Promotion of Clinical Immunology, Japan, Foundation of Association of International Education, Japan. Dr. Wang obtained his Ph.D. in Medical sciences from Osaka University, Japan and MD from Nantong University, Nantong, China.